Clearside Biomedical
Mark Prausnitz is a prominent figure in the biotechnology field, currently serving as Co-Founder at Alys Pharmaceuticals and Piezo Therapeutics, among others. With extensive experience as a co-founder and consultant across multiple companies, including Aldena Therapeutics and Microstar Biotech, Mark Prausnitz also plays significant roles at Micron Biomedical, Inc. and Clearside Biomedical. In addition to industry contributions, Mark Prausnitz is an academic leader as an Adjunct Professor of Biomedical Engineering at Emory University School of Medicine and a Regents' Professor at Georgia Institute of Technology. Mark Prausnitz holds a Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology and a Bachelor’s Degree in Chemical Engineering from Stanford University.
This person is not in any teams
This person is not in any offices
Clearside Biomedical
2 followers
Clearside Biomedical, Inc. is a clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye. The Company's product candidates focus on diseases affecting the retina, which is the tissue that lines t...